drugset / Trial / NCT03335527

Impacts of Low-Dose Dexmedetomidine on Sleep Quality in Mechanically Ventilated ICU Patients

NCT03335527 ↗

Phase 4 Completed 80 enrolled Peking University First Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Sleep disturbances frequently occur in intensive care unit (ICU) patients undergoing mechanical ventilation. In a previous study, sedative dose dexmedetomidine (median 0.6 microgram/kg/h) improved sleep quality in mechanically ventilated patients. However, for mechanically ventilated patients, light sedation is better than deep sedation for the outcomes, which is manifested as shortened length of ICU stay, shortened duration of mechanical ventilation, and decreased mortality. In a recent study of the investigators, non-sedative low-dose dexmedetomidine (0.1 microgram/kg/h) improved sleep quality in non-mechanically ventilated elderly patients admitted to the ICU after surgery. The investigators hypothesize that, in mechanically ventilated patients who are admitted to the ICU after surgery, low-dose dexmedetomidine may also improve sleep quality.

Timeline

Start
2017-11-17
Primary completion
2019-10-31
Completion
2019-11-30

Outcome

Missed primary endpoint

paper the difference was not statistically significant (median difference 8; 95% CI: -2, 22; P = 0.120). PMID 36117973 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous

Indications